News
January 10, 2022
TScan Outlines 2022 Priorities as Programs Enter Clinic
December 13, 2021
TScan Therapeutics Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition
December 3, 2021
TScan Therapeutics to Host a Virtual Event to Discuss Highlights from the 63rd ASH Annual Meeting and Exposition
December 2, 2021
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies
November 11, 2021
TScan Therapeutics to Participate in Upcoming Investor Conferences
November 10, 2021
TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
November 4, 2021
TScan Therapeutics Announces Upcoming Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition
October 5, 2021
TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations
September 28, 2021
TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference
September 9, 2021